<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(4)</volume><submitter>Urano T</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Thrombin activatable fibrinolysis inhibitor (TAFI) is one of the most important physiological fibrinolysis inhibitors. Its inhibitory efficacy under physiological conditions remains uncertain.&lt;h4>Objectives&lt;/h4>Elucidate the role of soluble thrombomodulin (sTM)/TAFI axis in the regulation of fibrinlysis.&lt;h4>Methods&lt;/h4>Since thrombin is required to generate activated TAFI (TAFIa) that targets the C-terminal lysine of partially digested fibrin, a clot lysis assay is suitable for evaluating its function. Using tissue-type plasminogen activator-induced plasma clot lysis time (tPA-PCLT) together with TAFIa inhibitor and recombinant sTM (rsTM), we evaluated the specific function of TM/TAFI in the plasma milieu.&lt;h4>Results&lt;/h4>tPA-PCLT values were significantly shortened by th</pubmed_abstract><journal>Research and practice in thrombosis and haemostasis</journal><pagination>102463</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11255936</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Evaluation of thrombomodulin/thrombin activatable fibrinolysis inhibitor function in plasma using tissue-type plasminogen activator-induced plasma clot lysis time.</pubmed_title><pmcid>PMC11255936</pmcid><pubmed_authors>Morooka N</pubmed_authors><pubmed_authors>Sano Y</pubmed_authors><pubmed_authors>Honkura N</pubmed_authors><pubmed_authors>Okada M</pubmed_authors><pubmed_authors>Suzuki Y</pubmed_authors><pubmed_authors>Doi M</pubmed_authors><pubmed_authors>Sano H</pubmed_authors><pubmed_authors>Urano T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evaluation of thrombomodulin/thrombin activatable fibrinolysis inhibitor function in plasma using tissue-type plasminogen activator-induced plasma clot lysis time.</name><description>&lt;h4>Background&lt;/h4>Thrombin activatable fibrinolysis inhibitor (TAFI) is one of the most important physiological fibrinolysis inhibitors. Its inhibitory efficacy under physiological conditions remains uncertain.&lt;h4>Objectives&lt;/h4>Elucidate the role of soluble thrombomodulin (sTM)/TAFI axis in the regulation of fibrinlysis.&lt;h4>Methods&lt;/h4>Since thrombin is required to generate activated TAFI (TAFIa) that targets the C-terminal lysine of partially digested fibrin, a clot lysis assay is suitable for evaluating its function. Using tissue-type plasminogen activator-induced plasma clot lysis time (tPA-PCLT) together with TAFIa inhibitor and recombinant sTM (rsTM), we evaluated the specific function of TM/TAFI in the plasma milieu.&lt;h4>Results&lt;/h4>tPA-PCLT values were significantly shortened by th</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2025-04-18T13:10:47.208Z</modification><creation>2025-04-06T22:45:41.39Z</creation></dates><accession>S-EPMC11255936</accession><cross_references><pubmed>39026660</pubmed><doi>10.1016/j.rpth.2024.102463</doi></cross_references></HashMap>